SCHEMBL4601734

SCHEMBL4601734

NCC(CS(=O)(=O)O)c1ccccc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABBR2 O75899 6/20 0.69
GABBR1 Q9UBS5 6/20 0.69
TAAR1 Q96RJ0 4/20 0.45
HTR2A P28223 1/20 0.45
CYP1A2 P05177 2/20 0.42
CYP2D6 P10635 2/20 0.42
PKM P14618 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
SRC P12931 1/20 0.41
ALDH1A1 P00352 1/20 0.40
SLC6A2 P23975 1/20 0.40
SLC6A4 P31645 1/20 0.40
SLC6A3 Q01959 1/20 0.40
LMNA P02545 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
CYP3A4 P08684 1/20 0.40
ADORA3 P0DMS8 1/20 0.40
NFKB1 P19838 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1859129 0.88 GABBR2 (0.52) GABBR2GABBR1CYP1A2CYP2D6PKM
SCHEMBL27509017 0.82 GABBR2 (0.47) GABBR2GABBR1CYP1A2CYP2D6PKM
SCHEMBL339758 0.81 GABBR2 (1.00) GABBR2GABBR1CYP1A2CYP2D6SMN1; SMN2
SCHEMBL28968674 0.81 GABBR2 (1.00) GABBR2GABBR1CYP1A2CYP2D6SMN1; SMN2
SCHEMBL339757 0.81 GABBR2 (1.00) GABBR2GABBR1CYP1A2CYP2D6SMN1; SMN2
SCHEMBL6728558 0.81 CCR5 (0.50) GABBR2GABBR1CYP1A2CYP2D6PKM
SCHEMBL28363012 0.79 GABBR2 (0.49) GABBR2GABBR1CYP1A2CYP2D6PKM
SCHEMBL2935549 0.77 SRC (0.48) GABBR2GABBR1TAAR1HTR2ACYP2D6
SCHEMBL28614078 0.77 GABBR2 (0.42) GABBR2GABBR1CYP1A2CYP2D6PKM
SCHEMBL28614077 0.77 GABBR2 (0.42) GABBR2GABBR1CYP1A2CYP2D6PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102659643-A Method for preparing substituted homotaurine from alpha, beta-unsaturated amide UNIV BEIJING CHEMICAL 2012-09-12 CN disclosed
EP-1812412-B1 SUBSTITUTED BENZOYLGUANIDINES METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENT OR DIAGNOSTIC AND MEDICAMENT COMPRISING THE SAME SANOFI AVENTIS DEUTSCHLAND (DE) 2008-04-23 EP disclosed
EP-1812412-A1 SUBSTITUTED BENZOYLGUANIDINES METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENT OR DIAGNOSTIC AND MEDICAMENT COMPRISING THE SAME Sanofi-Aventis Deutschland GmbH (DE) 2007-08-01 EP disclosed
WO-2006050830-A1 SUBSTITUTED BENZOYLGUANIDINES METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENT OR DIAGNOSTIC AND MEDICAMENT COMPRISING THE SAME SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2006-05-18 WO disclosed